The niche audience of industry-based decision makers attending Gene Therapy for Neurological Disorders are seeking commercial partners with expertise in:
- Neurodegenerative disorder drug development
- Neurological disorders rodent models
- Non-human primate (NHP) models
- Neurological biomarker technology
- CNS delivery technology
- Gene therapy design and manufacture
To find out more how to elevate your brand, form meaningful relationships with KOLs, and capture new business with emerging companies in the CNS field, don’t hesitate to get in touch with us to find out more about how we can build a bespoke package to suit your 2022 business needs.